Here are some key points about Zepbound: Composition and function: Contains tirzepatide, a compound also present in the diabetes medication Mounjaro Includes semaglutide and an additional hormone, GIP, to increase insulin secretion further and decrease appetite Acts as a dual agonist, activating both GLP-1 and GIP receptors Dosage and administration: Administered as a 2.5 mg weekly injection for the first month, then potentially increased to 5 mg weekly Dosage can be adjusted, with a maximum of 15 mg per week depending on individual needs and doctors guidance Indications and usage: Approved for use in adults 18 years and older with a body mass index (BMI) of 30 or higher (obese), or a BMI of 27 or higher (overweight) with at least one weight-related health condition To be used alongside a reduced-calorie diet and increased physical activity for optimal results Continuous usage may be necessary for maintaining weight loss, and patients should consider the benefits in relation to potential side effects and costs The efficacy of Zepbound in aiding weight loss is notable, with clinical trials showcasing significant results
Who May Want to Research the Zevay Program Further
controls at 1 year, but there was no significant difference in insulin dose between the semaglutide and control groups
Spencer Nadolsky, an obesity specialist and founder of a virtual health clinic specializing in GLP-1s, told BI that it's not advisable to change doses without consulting a doctor
